| 标题 |
619 Durvalumab plus carboplatin/paclitaxel followed by durvalumab ± olaparib as a first-line treatment for newly diagnosed advanced or recurrent endometrial cancer: results from the phase III DUO-E/GOG-3041/ENGOT-EN10 Trial |
| 网址 | |
| DOI |
10.1136/ijgc-2024-esgo.31
doi
|
| 其它 |
期刊:International Journal of Gynecological Cancer 作者:Shannon N. Westin; Kathleen N. Moore; Hye Sook Chon; Jung-Yun Lee; Jessica Thomes Pepin; et al 出版日期:2024-03-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)